Published in Cancer Weekly, October 2nd, 2007
Addressing this vital issue is a unique and innovative collaborative study, known as IMPACT, for "Improving Methods for Patient Accrual to Clinical Trials." Two institutions -- Weill...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.